Royce & Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Hold |
10,000
| – | – | 0.03% | 553 |
|
|
2025
Q1 | $3.08M | Hold |
10,000
| – | – | 0.03% | 521 |
|
|
2024
Q4 | $3.53M | Hold |
10,000
| – | – | 0.03% | 544 |
|
|
2024
Q3 | $3.58M | Hold |
10,000
| – | – | 0.03% | 538 |
|
|
2024
Q2 | $3.19M | Hold |
10,000
| – | – | 0.03% | 556 |
|
|
2024
Q1 | $2.3M | Hold |
10,000
| – | – | 0.02% | 615 |
|
|
2023
Q4 | $2.2M | Hold |
10,000
| – | – | 0.02% | 632 |
|
|
2023
Q3 | $2.26M | Hold |
10,000
| – | – | 0.02% | 628 |
|
|
2023
Q2 | $2.21M | Hold |
10,000
| – | – | 0.02% | 652 |
|
|
2023
Q1 | $2.24M | Hold |
10,000
| – | – | 0.02% | 635 |
|
|
2022
Q4 | $2.78M | Hold |
10,000
| – | – | 0.03% | 596 |
|
|
2022
Q3 | $2.09M | Hold |
10,000
| – | – | 0.02% | 622 |
|
|
2022
Q2 | $2.36M | Hold |
10,000
| – | – | 0.02% | 644 |
|
|
2022
Q1 | $1.79M | Hold |
10,000
| – | – | 0.02% | 730 |
|
|
2021
Q4 | $2.16M | Sell |
10,000
-93,000
| -90% | -$20.1M | 0.02% | 713 |
|
|
2021
Q3 | $19M | Sell |
103,000
-114,214
| -53% | -$21.1M | 0.14% | 218 |
|
|
2021
Q2 | $39M | Sell |
217,214
-6,684
| -3% | -$1.2M | 0.27% | 86 |
|
|
2021
Q1 | $37.5M | Buy |
223,898
+80,698
| +56% | +$13.5M | 0.25% | 98 |
|
|
2020
Q4 | $21.7M | Buy |
143,200
+78,500
| +121% | +$11.9M | 0.18% | 153 |
|
|
2020
Q3 | $6.54M | Buy |
+64,700
| New | +$6.54M | 0.07% | 411 |
|